Live Breaking News & Updates on Martinea rothblatt

Stay informed with the latest breaking news from Martinea rothblatt on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Martinea rothblatt and stay connected to the pulse of your community

California Public Employees Retirement System Sells 592 Shares of United Therapeutics Co. (NASDAQ:UTHR)

California Public Employees Retirement System trimmed its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 256,959 shares of the biotechnology company’s stock after selling 592 […]

United-states , California , Paula-mahon , Martinea-rothblatt , Nasdaq , Wells-fargo-company , United-therapeutics-corporation , Wealth-partners , Sumitomo-mitsui-ds-asset-management-company-ltd , United-therapeutics-co , Exchange-commission

Yousif Capital Management LLC Trims Stock Position in United Therapeutics Co. (NASDAQ:UTHR)

Yousif Capital Management LLC Trims Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Quebec , Canada , Martinea-rothblatt , Paula-mahon , United-therapeutics-corporation , Comerica-bank , United-therapeutics-co , Exchange-commission , Wells-fargo-company , Goldman-sachs-group

United Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Shares

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $236.47, for a total value of $851,292.00. Following the sale, the chief executive officer now owns 130 shares in the […]

United-states , Martinea-rothblatt , Nasdaq , Goldman-sachs-group , United-therapeutics-corporation , Cm-bidwell-associates-ltd , Rise-advisors , Ronald-blue-trust-inc , United-therapeutics-company-profile , United-therapeutics-co , Janiczek-wealth-management

United Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Shares

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the firm’s stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $236.47, for a total transaction of $851,292.00. Following the completion of the sale, the chief executive officer now directly owns […]

United-states , Martinea-rothblatt , Leerink-partnrs , Ronald-blue-trust-inc , Rise-advisors , Janiczek-wealth-management , United-therapeutics-co , Cm-bidwell-associates-ltd , United-therapeutics-corporation , Goldman-sachs-group , Securities-exchange-commission , Nasdaq

United Therapeutics Co. (NASDAQ:UTHR) CEO Martine A. Rothblatt Sells 3,600 Shares

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) CEO Martine A. Rothblatt sold 3,600 shares of the company’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $236.47, for a total value of $851,292.00. Following the sale, the chief executive officer now owns 130 shares in the […]

United-states , Martinea-rothblatt , Nasdaq , United-therapeutics-corporation , Goldman-sachs-group , Cm-bidwell-associates-ltd , Janiczek-wealth-management , United-therapeutics-co , United-therapeutics-company-profile , Ronald-blue-trust-inc , Rise-advisors

Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells $856,476.00 in Stock

Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells $856,476.00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blackrock , New-zealand-general- , New-zealand , United-states , Wellington , Martinea-rothblatt , Leerink-partnrs , Wells-fargo-company , Goldman-sachs-group , United-therapeutics-company-profile , Vanguard-group-inc , United-therapeutics-co

United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Kendall Capital Management

Kendall Capital Management increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 45.1% in the 4th quarter, HoldingsChannel reports. The firm owned 4,212 shares of the biotechnology company’s stock after purchasing an additional 1,310 shares during the period. Kendall Capital Management’s holdings in United Therapeutics were worth $926,000 as of […]

Alaska , United-states , Paula-mahon , Martinea-rothblatt , Goldman-sachs-group , Blue-trust-inc , Thrivent-financial-for-lutherans , United-therapeutics-corporation , Hermes-inc , Securities-exchange-commission , Wells-fargo-company

StockNews.com Downgrades United Therapeutics (NASDAQ:UTHR) to Buy

StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Tuesday morning. A number of other brokerages have also weighed in on UTHR. The Goldman Sachs Group upgraded United Therapeutics from a sell rating to a neutral rating and […]

Blackrock , New-zealand-general- , New-zealand , Wellington , United-states , Leerink-partnrs , Martinea-rothblatt , Paula-mahon , Wellington-management-group , Geode-capital-management , Goldman-sachs-group , Blackrock-inc

United Therapeutics (NASDAQ:UTHR) Shares Down 3.4% After Insider Selling

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report)’s stock price traded down 3.4% during mid-day trading on Wednesday following insider selling activity. The company traded as low as $236.07 and last traded at $239.32. 136,394 shares were traded during trading, a decline of 66% from the average session volume of 400,432 shares. The stock had […]

United-states , Martinea-rothblatt , Leerink-partnrs , Paula-mahon , United-therapeutics-corporation , United-therapeutics-company-profile , Nasdaq , Northwestern-mutual-wealth-management-co , Atlas-capital-advisors , United-therapeutics-co , Wells-fargo-company , Securities-exchange-commission

United Therapeutics (NASDAQ:UTHR) Shares Down 3.4% Following Insider Selling

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) fell 3.4% during mid-day trading on Wednesday following insider selling activity. The company traded as low as $236.07 and last traded at $239.32. 136,394 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 400,432 shares. The stock had […]

United-states , Blackrock , New-zealand-general- , New-zealand , Wellington , Martinea-rothblatt , Paula-mahon , Wellington-management-group , Nasdaq , Blackrock-inc , United-therapeutics-corporation